Buscar en RiuNet

Listar

Todo RiuNet

Mi cuenta

Acceder

Ayuda RiuNet

Admin. UPV

Listar por autor "Torres Ruiz, Sandra"

Mostrando ítems 1-4 de 4

MicroRNAs-449 implication in triple negative breast cancer aggressiveness through ACSL4 modulation

Arias Blanco, Laura (Universitat Politècnica de València, 2022-10-21)

[EN] Breast cancer have the highest cancer incidence rate in women worldwide. Within this pathology, different subtypes are divided according to histochemical and molecular classification. Specifically, the triple negative ...
MiRNA-449 family is epigenetically repressed and sensitizes to doxorubicin through ACSL4 downregulation in triple-negative breast cancer

Torres-Ruiz, Sandra; Garrido-Cano, Iris; Lameirinhas, Ana; Burgués, Octavio; Hernando, Cristina; Martínez, Maria Teresa; Rojo, Federico; Bermejo, Begoña; Tapia, Marta; Carbonell-Asins, Juan Antonio; Peña, Carlos Javier; Lluch, Ana; Cejalvo, Juan Miguel; Tormo, Eduardo; Eroles, Pilar (2024-08-22)

[EN] Despite progress in breast cancer treatment, a significant portion of patients still relapse because of drug resistance. The involvement of microRNAs in cancer progression and chemotherapy response is well established. ...
Papel de la familia de microRNAs-449 y el gen CDC20B en la respuesta a tratamientos en cáncer de mama: organoides y cultivos primarios como modelos tumorales

Torres Ruiz, Sandra (Universitat Politècnica de València, 2024-09-15)

[ES] El cáncer de mama triple negativo representa el 10-20% de los casos de cáncer de mama. Este subtipo molecular se caracteriza por su gran agresividad y capacidad invasiva y se asocia a un mal pronóstico. La ausencia ...
Role of SALL4 in HER2+Breast Cancer Progression: Regulating PI3K/AKT Pathway

Pattanayak, Birlipta; Trigo-Lameirinhas, Ana Catarina; Torres-Ruiz, Sandra; Burgués, Octavio; AURA ROVIRA, ANA MARÍA; Martínez, Maite; Tapia, Marta; Zazo, Sandra; Albanell, Joan; Rojo, Federico; Bermejo, Begoña; Eroles-Asensio, Pilar (MDPI AG, 2022-10-31)

[EN] Treatment for the HER2+ breast cancer subtype is still unsatisfactory, despite breakthroughs in research. The discovery of various new molecular mechanisms of transcription factors may help to make treatment regimens ...

Mostrando ítems 1-4 de 4

Listar por autor "Torres Ruiz, Sandra"

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Buscar en RiuNet

Listar

Todo RiuNet

Mi cuenta

Ayuda RiuNet

Admin. UPV

Listar por autor "Torres Ruiz, Sandra"